- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0304526

Endospy Pharmaceuticals Private Limited
About Endospy Pharmaceuticals Private Limited
Data last updated:
Endospy Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 15 August 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2022PTC213872.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by directors Yogita Prashant Jagadale and Prashant Bhanudas Jagadale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ashirwad Terrace Flat No C9 S No 31(P) Ingale Col Nda Road Shivane, Pune, Maharashtra, India – 411023.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.48 Lakh, a growth of 70% compared to the previous year. For the same year it recorded a net loss of ₹18,890 (net margin -2.2%) and EBITDA of -₹18,890 (EBITDA margin -2.2%).
Endospy Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0304526).
Company details
Recognitions & Rankings of Endospy Pharmaceuticals
Contact details
Endospy Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressAshirwad Terrace Flat No C9 S No 31(P) Ingale Col Nda Road Shivane, Pune, Maharashtra, India – 411023
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Endospy Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Endospy Pharmaceuticals Private Limited, buy the company report.
Financials of Endospy Pharmaceuticals Private Limited
FY 2025 filings availableEndospy Pharmaceuticals Private Limited reported revenue of ₹8.48 Lakh (up 70% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 70% in the latest year. EBITDA rose 74% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹18,890 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹18,890 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -2.2% | ||
| Net Profit Margin | -2.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Endospy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Endospy Pharmaceuticals Private Limited
Endospy Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogita Prashant Jagadale Also directs: Endovision Pharma Private Limited | Director | 15 Aug 2022 | 4 Years 2 Months | Current |
| Prashant Bhanudas Jagadale Also directs: Endovision Pharma Private Limited | Director | 15 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
Endospy Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zrox Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2021) | -6.0% | Yamuna Nagar, Haryana, India | |||
| Hyssop Pharmaceuticals Private Limited | ₹8.5 Lakh (FY 2024) | -55.0% | Ranchi, Jharkhand, India | |||
| Endospy Pharmaceuticals Private Limitedthis company | ₹8.48 Lakh (FY 2025) | -₹18,890 | -2.2% | 70.0% | Pune, Maharashtra, India | |
| Trans Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2021) | -85.0% | Ahmednagar, Maharashtra, India | |||
| Wellborn Pharmaceuticals Private Limited | ₹8.44 Lakh (FY 2018) | -43.0% | New Delhi, Delhi, India | |||
| Zelma Lifesciences Private Limited | ₹8.44 Lakh (FY 2025) | 48.0% | Chandigarh, India | |||
| Kon Pharmaceuticals Trading Private Limited | ₹8.43 Lakh (FY 2025) | 13.0% | Burdwan, West Bengal, India | |||
| Vagmin Pharmaceuticals Private Limited | ₹8.43 Lakh (FY 2019) | Bangalore, Karnataka, India |
To see the full peer comparison of Endospy Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Endospy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Endospy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Endospy Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Endospy Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Prashant Bhanudas Jagadale was appointed as Director on 15 Aug 2022.
Frequently asked questions
Endospy Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 15 August 2022 (4+ years old) and is registered under CIN U24230PN2022PTC213872.
Endospy Pharmaceuticals has 2 current directors:
- Yogita Prashant Jagadale - Director
- Prashant Bhanudas Jagadale - Director
The latest financial statements of Endospy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Endospy Pharmaceuticals is U24230PN2022PTC213872. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Endospy Pharmaceuticals was incorporated on 15 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Endospy Pharmaceuticals by revenue are Zrox Pharmaceuticals Private Limited, Hyssop Pharmaceuticals Private Limited, Trans Pharmaceuticals Private Limited, Wellborn Pharmaceuticals Private Limited, Zelma Lifesciences Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Prashant Bhanudas Jagadale was appointed as Director on 15 Aug 2022. Yogita Prashant Jagadale was appointed as Director on 15 Aug 2022.
Yes, Endospy Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0304526).
The registered office of Endospy Pharmaceuticals is at Ashirwad Terrace Flat No C9 S No 31P Ingale Col Nda Road Shivane, Pune, Maharashtra, India – 411023.
Endospy Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Endospy Pharmaceuticals can be reached at its registered office: Ashirwad Terrace Flat No C9 S No 31P Ingale Col Nda Road Shivane, Pune, Maharashtra, India – 411023.

